Cambridge Investment Research Advisors’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-74,880
Closed -$681K – 3854
2025
Q3
$681K Buy
74,880
+1,259
+2% +$15.7K ﹤0.01% 2378
2025
Q2
$1.13M Buy
73,621
+53,376
+264% +$899K ﹤0.01% 1857
2025
Q1
$395K Buy
20,245
+560
+3% +$15.5K ﹤0.01% 2650
2024
Q4
$608K Sell
19,685
-166
-0.8% -$4.54K ﹤0.01% 2266
2024
Q3
$507K Buy
19,851
+2,459
+14% +$73.8K ﹤0.01% 2408
2024
Q2
$509K Buy
17,392
+7,482
+75% +$222K ﹤0.01% 2284
2024
Q1
$377K Sell
9,910
-4,358
-31% -$262K ﹤0.01% 2523
2023
Q4
$1.11M Buy
14,268
+17
+0.1% +$1.05K ﹤0.01% 1579
2023
Q3
$817K Buy
+14,251
New +$743K ﹤0.01% 1703
2022
Q2
– Sell
-1,987
Closed -$264K – 3084
2022
Q1
$264K Sell
1,987
-3,415
-63% -$430K ﹤0.01% 2651
2021
Q4
$907K Buy
5,402
+671
+14% +$104K ﹤0.01% 1640
2021
Q3
$643K Buy
4,731
+2,261
+92% +$292K ﹤0.01% 1851
2021
Q2
$280K Buy
2,470
+90
+4% +$8.7K ﹤0.01% 2523
2021
Q1
$202K Buy
+2,380
New +$199K ﹤0.01% 2617

Other funds holding DAVA

Cambridge Investment Research Advisors's DAVA Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of Endava (DAVA) in Q4 2025, closing a stake of 74,880 shares — an estimated $681K sold.

Cambridge Investment Research Advisors first reported a position in DAVA in Q1 2021 and held it in 14 quarters. The position peaked at $1.13M in Q2 2025. 101 funds tracked by Wall St. Rank hold DAVA as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining Endava position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 74,880 Endava shares in Q4 2025, an estimated $681K.
  • Cambridge Investment Research Advisors first reported a position in Endava in Q1 2021 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Endava position peaked at $1.13M in Q2 2025.
  • 101 funds tracked by Wall St. Rank held Endava as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.